330 related articles for article (PubMed ID: 16681641)
1. Diverse niches within multiple myeloma bone marrow aspirates affect plasma cell enumeration.
Nadav L; Katz BZ; Baron S; Yossipov L; Polliack A; Deutsch V; Geiger B; Naparstek E
Br J Haematol; 2006 Jun; 133(5):530-2. PubMed ID: 16681641
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
3. [Optimizing plasma cell content in bone marrow aspirates].
Hoffmann T; Favre G; Gratwohl A; Passweg J; Mathys S; Borel J; Speck B; Tichelli A
Schweiz Med Wochenschr; 1998 Oct; 128(42):1611-3. PubMed ID: 9824893
[TBL] [Abstract][Full Text] [Related]
4. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
5. Using aspirates for multiple myeloma research probably excludes important data.
Ely S
Br J Haematol; 2006 Jul; 134(2):245-6. PubMed ID: 16846488
[No Abstract] [Full Text] [Related]
6. The generation and regulation of functional diversity of malignant plasma cells.
Nadav L; Katz BZ; Baron S; Cohen N; Naparstek E; Geiger B
Cancer Res; 2006 Sep; 66(17):8608-16. PubMed ID: 16951174
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartments.
Kumar S; Rajkumar SV; Greipp PR; Witzig TE
Am J Hematol; 2004 Sep; 77(1):7-11. PubMed ID: 15307099
[TBL] [Abstract][Full Text] [Related]
8. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma.
Frébet E; Abraham J; Geneviève F; Lepelley P; Daliphard S; Bardet V; Amsellem S; Guy J; Mullier F; Durrieu F; Venon MD; Leleu X; Jaccard A; Faucher JL; Béné MC; Feuillard J;
Cytometry B Clin Cytom; 2011 May; 80(3):176-85. PubMed ID: 21520405
[TBL] [Abstract][Full Text] [Related]
9. Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors.
Peceliunas V; Janiulioniene A; Matuzeviciene R; Griskevicius L
Cytometry B Clin Cytom; 2011 Sep; 80(5):318-23. PubMed ID: 21634008
[TBL] [Abstract][Full Text] [Related]
10. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
11. Single tube, six-color flow cytometric analysis is a sensitive and cost-effective technique for assaying clonal plasma cells.
Marsee DK; Li B; Dorfman DM
Am J Clin Pathol; 2010 May; 133(5):694-9. PubMed ID: 20395515
[TBL] [Abstract][Full Text] [Related]
12. Utility of CD56 immunohistochemical studies in follow-up of plasma cell myeloma.
Harrington AM; Hari P; Kroft SH
Am J Clin Pathol; 2009 Jul; 132(1):60-6. PubMed ID: 19864234
[TBL] [Abstract][Full Text] [Related]
13. Optimization of a flow cytometry-based protocol for detection and phenotypic characterization of multipotent mesenchymal stromal cells from human bone marrow.
Jones EA; English A; Kinsey SE; Straszynski L; Emery P; Ponchel F; McGonagle D
Cytometry B Clin Cytom; 2006 Nov; 70(6):391-9. PubMed ID: 16977637
[TBL] [Abstract][Full Text] [Related]
14. Digital image analysis of mean AgNOR area objectively discriminates between reactive plasmacytosis and multiple myeloma in cytologic smears from bone marrow aspirates.
Gunia S; Mai PA; Koch S
Pathobiology; 2008; 75(5):306-11. PubMed ID: 18931533
[TBL] [Abstract][Full Text] [Related]
15. [Cytopathological features of multiple myeloma].
Takeuchi T; Adachi Y; Ikezoe T; Yokoyama A; Furihata M; Ohtsuki Y
Nihon Rinsho; 2007 Dec; 65(12):2250-5. PubMed ID: 18069269
[TBL] [Abstract][Full Text] [Related]
16. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates.
Cogbill CH; Spears MD; Vantuinen P; Harrington AM; Olteanu H; Kroft SH
Int J Lab Hematol; 2015 Dec; 37(6):797-808. PubMed ID: 26224420
[TBL] [Abstract][Full Text] [Related]
17. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
18. Instability of immunophenotype in plasma cell myeloma.
Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
[TBL] [Abstract][Full Text] [Related]
19. Measurable disease evaluation in patients with myeloma.
Roshal M
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101154. PubMed ID: 32139019
[TBL] [Abstract][Full Text] [Related]
20. Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.
Yuan CM; Stetler-Stevenson M
Semin Hematol; 2011 Jan; 48(1):32-8. PubMed ID: 21232656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]